Monitoring of minimal residual disease in early T‐cell precursor acute lymphoblastic leukaemia by next‐generation sequencing

T Cell ◽

Lymphoblastic Leukaemia ◽

Residual Disease ◽

Next Generation ◽

Cell Precursor ◽

Generation Sequencing ◽

Test trial of spike‐in immunoglobulin heavy‐chain ( IGH ) controls for next generation sequencing quantification of minimal residual disease in acute lymphoblastic leukaemia

British Journal of Haematology ◽

10.1111/bjh.16571 ◽

2020 ◽

Vol 189 (4) ◽

Author(s):

Guilherme Navarro Nilo Giusti ◽

Patrícia Yoshioka Jotta ◽

Caroline de Oliveira Lopes ◽

Monica Aparecida Ganazza ◽

Amilcar Cardoso Azevedo ◽

...

Keyword(s):

Test Trial ◽

Heavy Chain ◽

Lymphoblastic Leukaemia ◽

Residual Disease ◽

Next Generation ◽

Generation Sequencing ◽

Clinical utility of next-generation sequencing-based minimal residual disease in paediatric B-cell acute lymphoblastic leukaemia

British Journal of Haematology ◽

10.1111/bjh.14420 ◽

2016 ◽

Vol 176 (2) ◽

pp. 248-257 ◽

Cited By ~ 15

Author(s):

Yuko Sekiya ◽

Yinyan Xu ◽

Hideki Muramatsu ◽

Yusuke Okuno ◽

Atsushi Narita ◽

...

Keyword(s):

B Cell ◽

Lymphoblastic Leukaemia ◽

Clinical Utility ◽

Residual Disease ◽

Next Generation ◽

Generation Sequencing ◽

Next‐generation sequencing of PTEN mutations for monitoring minimal residual disease in T‐cell acute lymphoblastic leukemia

Pediatric Blood & Cancer ◽

10.1002/pbc.28025 ◽

2019 ◽

Vol 67 (1) ◽

Cited By ~ 1

Author(s):

Giuseppe Germano ◽

Maria Grazia Valsecchi ◽

Barbara Buldini ◽

Giovanni Cazzaniga ◽

Carlo Zanon ◽

...

Keyword(s):

Acute Lymphoblastic Leukemia ◽

T Cell ◽

Residual Disease ◽

Lymphoblastic Leukemia ◽

Next Generation ◽

Cell Acute Lymphoblastic Leukemia ◽

Generation Sequencing ◽

Next Generation Sequencing（NGS）Monitors Minimal Residual Disease（MRD）in Allo-PBSCT Patients

Case Medical Research ◽

10.31525/ct1-nct04126967 ◽

2019 ◽

Author(s):

Keyword(s):

Residual Disease ◽

Next Generation ◽

Next Generation Sequencing Ngs ◽

Generation Sequencing ◽

Upgraded Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma

Journal of Molecular Diagnostics ◽

10.1016/j.jmoldx.2020.02.005 ◽

2020 ◽

Vol 22 (5) ◽

pp. 679-684 ◽

Cited By ~ 1

Author(s):

Qiumei Yao ◽

Yinlei Bai ◽

Alberto Orfao ◽

Shaji Kumar ◽

Chor S. Chim

Keyword(s):

Multiple Myeloma ◽

Residual Disease ◽

Disease Detection ◽

Next Generation ◽

Minimal Residual Disease Detection ◽

Generation Sequencing ◽

Next generation sequencing as the new gold standard for minimal residual disease detection in B-ALL

Journal of Laboratory and Precision Medicine ◽

10.21037/jlpm.2018.11.04 ◽

2018 ◽

Vol 3 ◽

pp. 97-97

Author(s):

Rosa Ayala ◽

Esther Onecha

Keyword(s):

Gold Standard ◽

Residual Disease ◽

Disease Detection ◽

Next Generation ◽

Minimal Residual Disease Detection ◽

Generation Sequencing ◽

Advancements in Next-Generation Sequencing for Detecting Minimal Residual Disease

Minimal Residual Disease Testing ◽

10.1007/978-3-319-94827-0_6 ◽

2018 ◽

pp. 159-192

Author(s):

Erin L. Crowgey ◽

Nitin Mahajan

Keyword(s):

Residual Disease ◽

Next Generation ◽

Generation Sequencing ◽

Next-Generation Sequencing Technology to Identify Minimal Residual Disease in Lymphoid Malignancies

Leukemia Stem Cells - Methods in Molecular Biology ◽

10.1007/978-1-0716-0810-4_7 ◽

2020 ◽

pp. 95-111

Author(s):

Michaela Kotrova ◽

◽

Nikos Darzentas ◽

Christiane Pott ◽

Monika Brüggemann

Keyword(s):

Residual Disease ◽

Next Generation ◽

Sequencing Technology ◽

Next Generation Sequencing Technology ◽

Lymphoid Malignancies ◽

Generation Sequencing Technology ◽

Generation Sequencing ◽

Minimal Residual Disease by Next-Generation Sequencing: Pros and Cons

American Society of Clinical Oncology Educational Book ◽

10.14694/edbk_159088 ◽

2016 ◽

Vol 36 ◽

pp. e425-e430 ◽

Cited By ~ 6

Author(s):

Herve Avet-Loiseau

Keyword(s):

Residual Disease ◽

Next Generation ◽

Pros And Cons ◽

Generation Sequencing ◽

Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study

Medical Oncology ◽

10.1007/s12032-015-0582-2 ◽

2015 ◽

Vol 32 (4) ◽

Author(s):

Emma Bergfelt ◽

Piotr Kozlowski ◽

Lucia Ahlberg ◽

Erik Hulegårdh ◽

Hans Hägglund ◽

...

Keyword(s):

B Cell ◽

Lymphoblastic Leukaemia ◽

Older Patients ◽

Residual Disease ◽

Intensive Chemotherapy ◽

Cell Precursor ◽

Satisfactory Outcome ◽